NFACX
Price
$32.55
Change
+$0.29 (+0.90%)
Updated
Jul 3 closing price
Net Assets
791.68M
RNPHX
Price
$69.46
Change
+$0.38 (+0.55%)
Updated
Jul 3 closing price
Net Assets
156.22B
Interact to see
Advertisement

NFACX vs RNPHX

Header iconNFACX vs RNPHX Comparison
Open Charts NFACX vs RNPHXBanner chart's image
Neuberger Berman Focus C
Price$32.55
Change+$0.29 (+0.90%)
VolumeN/A
Net Assets791.68M
American Funds New Perspective R5E
Price$69.46
Change+$0.38 (+0.55%)
VolumeN/A
Net Assets156.22B
NFACX vs RNPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NFACX vs. RNPHX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NFACX is a Buy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 156B vs. NFACX (792M). RNPHX pays higher dividends than NFACX: RNPHX (0.67) vs NFACX (0.00). NFACX was incepted earlier than RNPHX: NFACX (15 years) vs RNPHX (10 years). NFACX (1.96) is less costly to investors than RNPHX (0.56). NFACX is a more actively managed with annual turnover of: 38.00 vs. RNPHX (24.00). RNPHX has a lower initial minimum investment than NFACX: RNPHX (250) vs NFACX (1000). NFACX annual gain was more profitable for investors over the last year : 18.49 vs. RNPHX (11.41). RNPHX return over 5 years is better than : 46.57 vs. NFACX (27.20).
NFACXRNPHXNFACX / RNPHX
Total Expense Ratio1.870.56334%
Annual Report Gross Expense Ratio1.960.56350%
Fund Existence15 years10 years-
Gain YTD13.61313.053104%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets792M156B1%
Annual Yield % from dividends0.000.67-
Returns for 1 year18.4911.41162%
Returns for 3 years66.2446.75142%
Returns for 5 years27.2046.5758%
Returns for 10 years-40.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPHI1.840.10
+5.44%
China Pharma Holdings Inc
VRT127.843.51
+2.82%
Vertiv Holdings Co
UTL52.520.37
+0.71%
Unitil Corp
EVH11.790.06
+0.51%
Evolent Health
VYGR3.20N/A
N/A
Voyager Therapeutics